跳至主要内容
临床试验/NCT01666587
NCT01666587已完成不适用

The Role of Prostaglandin and Anti-oxidant Availability on Recovery From Forearm Ischemia-reperfusion Injury in Humans

University of Essex1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Change in flow mediated dilation

研究概览

简要总结

The purposes of this study are two-fold. The first purpose is to determine the effect of taking vitamins on the recovery of an artery (blood vessel) following an induced temporary injury. The second purpose is to determine whether a specific vasodilator is less abundant after the injury and whether this contributes to increased constriction or after the injury. Finally, does vitamin consumption have an effect on the recovery from the injury if one of the substances in the blood that causes vessels to enlarge (dilate) is stopped?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy males
  • Healthy females

排除标准

  • Cardiovascular disease
  • Peripheral vascular disease
  • Neurological deficits
  • Diabetes Type I or II
  • Pregnant women
  • Adverse reactions to Ibuprofen

研究组 & 干预措施

Antioxidant load

Experimental

Trial to determine the impact of an antioxidant load before the ischemic injury on vascular function recovery

干预措施: Antioxidant (Dietary Supplement)

Prostaglandin inhibition

Experimental

Trial to determine the impact of a non-selective prostaglandin inhibitor before the ischemic injury on vascular function recovery

干预措施: Prostaglandin inhibitor (Ibuprophen) (Drug)

Combined

Experimental

Trial to determine the impact of an antioxidant load and prostaglandin inhibitor before the ischemic injury on vascular function recovery

干预措施: Antioxidant (Dietary Supplement)

Combined

Experimental

Trial to determine the impact of an antioxidant load and prostaglandin inhibitor before the ischemic injury on vascular function recovery

干预措施: Prostaglandin inhibitor (Ibuprophen) (Drug)

结局指标

主要结局

Change in flow mediated dilation

时间窗: Change from baseline at 15 minutes after ischemia-reperfusion injury

Flow mediated dilation is a measure of vascular function and is measured as the outcome before and after an injury to the inner lining of the artery.

次要结局

  • Change in low flow mediated constriction(Change from baseline at 15 minutes after ischemia-reperfusion injury)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark Rakobowchuk

Principle Investigator

University of Essex

研究点 (1)

Loading locations...

相似试验